# Inflammation and Vascular Function in Atherosclerosis

> **NCT00760019** · PHASE2,PHASE3 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 58 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** salsalate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00760019
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-10
- **Final completion:** 2011-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760019, "Inflammation and Vascular Function in Atherosclerosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00760019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*